Sophie Vanhaesebrouck

1.5k total citations
35 papers, 1.1k citations indexed

About

Sophie Vanhaesebrouck is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sophie Vanhaesebrouck has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pediatrics, Perinatology and Child Health, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sophie Vanhaesebrouck's work include Neonatal Respiratory Health Research (11 papers), Neonatal Health and Biochemistry (8 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Sophie Vanhaesebrouck is often cited by papers focused on Neonatal Respiratory Health Research (11 papers), Neonatal Health and Biochemistry (8 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Sophie Vanhaesebrouck collaborates with scholars based in Belgium, Netherlands and United Kingdom. Sophie Vanhaesebrouck's co-authors include Karel Allegaert, Christine Vanhole, Francis de Zegher, Claire Theyskens, Brian J. Anderson, John N. van den Anker, David B. Dunger, Paula Midgley, Amanda Ogilvy‐Stuart and Luc Cornette and has published in prestigious journals such as New England Journal of Medicine, Antimicrobial Agents and Chemotherapy and The Journal of Pediatrics.

In The Last Decade

Sophie Vanhaesebrouck

34 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sophie Vanhaesebrouck Belgium 15 471 334 333 236 184 35 1.1k
Vasileios Giapros Greece 19 542 1.2× 115 0.3× 238 0.7× 76 0.3× 240 1.3× 81 996
Chad Andersen Australia 21 770 1.6× 75 0.2× 1.3k 3.8× 87 0.4× 202 1.1× 67 1.9k
Jean‐Pierre Fauvel France 16 96 0.2× 111 0.3× 86 0.3× 34 0.1× 84 0.5× 68 883
Daniel A. Kveselis United States 15 94 0.2× 95 0.3× 489 1.5× 56 0.2× 545 3.0× 27 1.2k
Jonathan R. Swanson United States 20 492 1.0× 31 0.1× 700 2.1× 66 0.3× 240 1.3× 54 1.4k
Henry J. Rozycki United States 17 378 0.8× 75 0.2× 1.0k 3.1× 60 0.3× 194 1.1× 49 1.4k
Lothar Engelmann Germany 15 40 0.1× 88 0.3× 349 1.0× 84 0.4× 121 0.7× 18 1.2k
J.-P. Guignard Switzerland 16 481 1.0× 36 0.1× 419 1.3× 54 0.2× 66 0.4× 45 1.0k
Dharmapuri Vidyasagar United States 21 506 1.1× 17 0.1× 1.1k 3.4× 157 0.7× 216 1.2× 110 1.6k
Yves W. Brans United States 22 443 0.9× 113 0.3× 478 1.4× 18 0.1× 103 0.6× 79 1.3k

Countries citing papers authored by Sophie Vanhaesebrouck

Since Specialization
Citations

This map shows the geographic impact of Sophie Vanhaesebrouck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Vanhaesebrouck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Vanhaesebrouck more than expected).

Fields of papers citing papers by Sophie Vanhaesebrouck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Vanhaesebrouck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Vanhaesebrouck. The network helps show where Sophie Vanhaesebrouck may publish in the future.

Co-authorship network of co-authors of Sophie Vanhaesebrouck

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Vanhaesebrouck. A scholar is included among the top collaborators of Sophie Vanhaesebrouck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Vanhaesebrouck. Sophie Vanhaesebrouck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Roets, Ellen, Kim Beernaert, Kenneth Chambaere, et al.. (2023). Pregnancy termination at a viable stage in daily clinical practice: A nationwide mortality follow‐back study in Flanders, Belgium. Prenatal Diagnosis. 43(6). 781–791. 1 indexed citations
3.
Somers, Annemie, Sophie Vanhaesebrouck, Rob ter Heine, et al.. (2021). Variation in vancomycin dosing and therapeutic drug monitoring practices in neonatal intensive care units. International Journal of Clinical Pharmacy. 44(2). 564–569. 4 indexed citations
4.
Keymeulen, Annelies, Els De Leenheer, Alexandra Casaer, et al.. (2021). Cranial ultrasound and MRI: complementary or not in the diagnostic assessment of children with congenital CMV infection?. European Journal of Pediatrics. 181(3). 911–920. 18 indexed citations
5.
Salaets, Thomas, Anne Smits, Sophie Vanhaesebrouck, et al.. (2020). Parental perspectives long term after neonatal clinical trial participation: a survey. Trials. 21(1). 907–907. 1 indexed citations
6.
Dereymaeker, A, Sophie Vanhaesebrouck, Katrien Jansen, et al.. (2015). Transient hypothyroidism associated with viral Human Parechovirus encephalitis in a newborn. European Journal of Paediatric Neurology. 19(6). 706–710. 2 indexed citations
7.
Beardsall, Kathryn, Sophie Vanhaesebrouck, Jan Frystyk, et al.. (2014). Relationship between Insulin-Like Growth Factor I Levels, Early Insulin Treatment, and Clinical Outcomes of Very Low Birth Weight Infants. The Journal of Pediatrics. 164(5). 1038–1044.e1. 26 indexed citations
8.
Cock, Roosmarijn F. W. De, Karel Allegaert, Sophie Vanhaesebrouck, et al.. (2013). Low but Inducible Contribution of Renal Elimination to Clearance of Propylene Glycol in Preterm and Term Neonates. Therapeutic Drug Monitoring. 36(3). 278–287. 12 indexed citations
9.
Allegaert, Karel, Gunnar Naulaers, Sophie Vanhaesebrouck, & Brian J. Anderson. (2012). The paracetamol concentration‐effect relation in neonates. Pediatric Anesthesia. 23(1). 45–50. 51 indexed citations
10.
Breysem, Luc, et al.. (2012). Multidetector CT of right-sided congenital diaphragmatic hernia associated with hepatopulmonary fusion in a newborn. Pediatric Radiology. 42(9). 1138–1141. 8 indexed citations
11.
Allegaert, Karel, Sophie Vanhaesebrouck, Aida Kulo, et al.. (2010). Prospective assessment of short-term propylene glycol tolerance in neonates. Archives of Disease in Childhood. 95(12). 1054–1058. 39 indexed citations
12.
Allegaert, Karel, Sophie Vanhaesebrouck, René Verbesselt, & John N. van den Anker. (2009). In Vivo Glucuronidation Activity of Drugs in Neonates: Extensive Interindividual Variability Despite Their Young Age. Therapeutic Drug Monitoring. 31(4). 411–415. 51 indexed citations
13.
Vanhaesebrouck, Sophie, Johannes M. A. Daniels, Lieve Moons, et al.. (2009). Oxygen-Induced Retinopathy in Mice: Amplification by Neonatal IGF-I Deficit and Attenuation by IGF-I Administration. Pediatric Research. 65(3). 307–310. 72 indexed citations
14.
Beardsall, Kathryn, Sophie Vanhaesebrouck, Amanda Ogilvy‐Stuart, et al.. (2008). Early Insulin Therapy in Very-Low-Birth-Weight Infants. New England Journal of Medicine. 359(18). 1873–1884. 212 indexed citations
15.
Vanhaesebrouck, Sophie, Myriam Hanssens, & Karel Allegaert. (2008). Neonatal transient respiratory depression after maternal urapidil infusion for hypertension. European Journal of Pediatrics. 168(2). 221–223. 6 indexed citations
16.
Allegaert, Karel, Maissa Rayyan, Sophie Vanhaesebrouck, & Gunnar Naulaers. (2008). Developmental pharmacokinetics in neonates. Expert Review of Clinical Pharmacology. 1(3). 415–428. 6 indexed citations
17.
Beardsall, Kathryn, Sophie Vanhaesebrouck, Amanda Ogilvy‐Stuart, et al.. (2007). A randomised controlled trial of early insulin therapy in very low birth weight infants, "NIRTURE" (neonatal insulin replacement therapy in Europe). BMC Pediatrics. 7(1). 29–29. 35 indexed citations
18.
Vanhaesebrouck, Sophie, et al.. (2007). Conservative treatment for patent ductus arteriosus in the preterm. Archives of Disease in Childhood Fetal & Neonatal. 92(4). F244–F247. 87 indexed citations
19.
Allegaert, Karel, Brian J. Anderson, John N. van den Anker, Sophie Vanhaesebrouck, & Francis de Zegher. (2007). Renal Drug Clearance in Preterm Neonates: Relation to Prenatal Growth. Therapeutic Drug Monitoring. 29(3). 284–291. 78 indexed citations
20.
Allegaert, Karel, Christine Vanhole, Maria Van Helvoirt, et al.. (2004). Association of patent ductus arteriosus and severe hypothyroidism in term newborns: coincidence or causal?. The Journal of Maternal-Fetal & Neonatal Medicine. 16(6). 339–341. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vasileios Giapros Breakdown of academic impact, for papers by Chad Andersen Breakdown of academic impact, for papers by Jean‐Pierre Fauvel Breakdown of academic impact, for papers by Daniel A. Kveselis Breakdown of academic impact, for papers by Jonathan R. Swanson Breakdown of academic impact, for papers by Henry J. Rozycki Breakdown of academic impact, for papers by Lothar Engelmann Breakdown of academic impact, for papers by J.-P. Guignard Breakdown of academic impact, for papers by Dharmapuri Vidyasagar Breakdown of academic impact, for papers by Yves W. Brans
Rankless by CCL
2026